Live from the NIH registry
Studies recruiting near Fairfield right now
Top 25 of 348 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Northbay Cancer Center — Vacaville, California (7.2 mi)
· Sponsor: SWOG Cancer Research Network
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,490 participants sought
Research Site — Walnut Creek, California (24.4 mi)
· Sponsor: AstraZeneca
MMA Embolization for Refractory Chronic Migraine
Migraine Disorders
N/A
Interventional 70 participants sought
John Muir Physician Network Clin. Research Center — Walnut Creek, California (24.4 mi)
· Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Kaiser Permanente Medical Center — Vallejo, California (16.1 mi)
· Sponsor: Relay Therapeutics, Inc.
Alcohol-ROC-Training
Binge Drinking, Heavy Drinking
N/A
Interventional 177 participants sought
University of California, Berkeley — Berkeley, California (29.7 mi)
· Sponsor: Yale University
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Geographic Atrophy, Macular Degeneration
Phase 2
Interventional 274 participants sought
Bay Area Retina Associates — Walnut Creek, California (24.4 mi)
· Sponsor: Janssen Research & Development, LLC
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Sunwise Clinical Research /ID# 270431 — Walnut Creek, California (24.4 mi)
· Sponsor: AbbVie
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Kaiser Permanente-Vallejo — Vallejo, California (16.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 1,200 participants sought
Alta Bates Summit Medical Center ( Site 0004) — Berkeley, California (29.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Obesity, Knee Osteoarthritis (OA)
Phase 3
Interventional 400 participants sought
Diablo Clinical Research, Inc. — Walnut Creek, California (24.4 mi)
· Sponsor: Novo Nordisk A/S
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Episodic Migraine
Phase 3
Interventional 450 participants sought
Sunwise Clinical Research /ID# 248529 — Walnut Creek, California (24.4 mi)
· Sponsor: AbbVie
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Kaiser Permanente Vallejo Medical Center ( Site 0060) — Vallejo, California (16.1 mi)
· Sponsor: Merck Sharp & Dohme LLC
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
Graves Disease
Phase 3
Interventional 300 participants sought
Site-067 — Walnut Creek, California (24.4 mi)
· Sponsor: Biohaven Therapeutics Ltd.
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Providence Queen of The Valley — Napa, California (13.9 mi)
· Sponsor: SWOG Cancer Research Network
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Kaiser Permanente-Vallejo — Vallejo, California (16.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Menstrual Migraine
Phase 3
Interventional 723 participants sought
Diablo Clinical Research, Inc. — Walnut Creek, California (24.4 mi)
· Sponsor: Pfizer
AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss
Obesity
Phase 3
Interventional 600 participants sought
Diablo Clinical Research, Inc. — Walnut Creek, California (24.4 mi)
· Sponsor: Novo Nordisk A/S
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
Sunwise Clinical Research — Walnut Creek, California (24.4 mi)
· Sponsor: Kallyope Inc.
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8
Phase 3
Interventional 474 participants sought
Sutter Solano Medical Center/Cancer Center — Vallejo, California (16.1 mi)
· Sponsor: NRG Oncology
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Alzheimer Disease, Dementia
Phase 3
Interventional 550 participants sought
Infectious Disease Doctors Medical Group, APC — Walnut Creek, California (24.4 mi)
· Sponsor: Eli Lilly and Company
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
Providence Queen of The Valley — Napa, California (13.9 mi)
· Sponsor: SWOG Cancer Research Network
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Phase 3
Interventional 582 participants sought
Research Site — Walnut Creek, California (24.4 mi)
· Sponsor: AstraZeneca
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Hereditary Angioedema, HAE
Phase 3
Interventional 90 participants sought
ADARx Clinical Site — Walnut Creek, California (24.4 mi)
· Sponsor: ADARx Pharmaceuticals, Inc.
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
Major Depressive Disorder
Phase 4
Interventional 350 participants sought
Clinical Research Site — Lafayette, California (26.1 mi)
· Sponsor: Axsome Therapeutics, Inc.
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Kaiser Permanente Medical Center-Vacaville — Vacaville, California (7.2 mi)
· Sponsor: NRG Oncology